Document
FDA review finds additional data supports the potential for increased long-term risks with antibiotic clarithromycin (Biaxin) in
ICR 202205-0910-005 · OMB 0910-0847 · Object 121560401.
This document may belong to an older filing. More recent activity for OMB 0910-0847:
Document Viewer [pdf]
Status: Original and derived artifacts are available for this document.
Download: pdf
Loading document viewer…
Document Metadata
| File Type | application/octet-stream |
|---|---|
| File Title | FDA review finds additional data supports the potential for increased long-term risks with antibiotic clarithromycin (Biaxin) in |
| Subject | 2 |
| Author | FDA/CDER |
| File Modified | 2018-06-13 |
| File Created | 2018-02-22 |
| Conversion State | complete |